Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression.
Sign Up to like & getrecommendations! Published in 2022 at "Digestive diseases and sciences"
DOI: 10.1158/1538-7445.am2022-6367
Abstract: BACKGROUND Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis due to its therapeutic resistance. Inactivation of vitamin D/vitamin D receptor (VDR) signaling may contribute to the malignant phenotype of PDA and altered expression of oncoprotein… read more here.
Keywords: vitamin vdr; expression; resistance; vdr signaling ... See more keywords